Alan Roemer

Alan Roemer

Président chez
UTILITY therapeutics Ltd.

Fortune : 92 591 $ au 31/05/2026

56 ans
Health Technology
Consumer Services
Finance

Profil

Alan S.
Roemer
is Chairman at UTILITY therapeutics Ltd. since 2020.
Mr. Roemer is Director at DC Brau Brewing LLC.
Mr. Roemer is Trustee at Helene Fuld College of Nursing since 2014.
Former roles include Chairman at IN8bio, Inc. from 2020 to 2026, Director at Bit Bio Ltd. from 2021 to 2024, Managing Director at Trout Capital LLC from 2009 to 2014, Director at Sompharmaceuticals SA from 2012 to 2016, Managing Director at The Trout Group LLC from 2009 to 2014, Director at Envisagenics, Inc. from 2021 to 2023, Independent Director at NexImmune, Inc. from 2019 to 2024, Principal at Bank of America Corp., Chief Financial Officer & Treasurer at Azelon Pharmaceuticals, Inc. from 2008 to 2009, Vice President-Investor Relations at Pharmasset, Inc. from 1999 to 2008, Consultant at Deloitte Consulting LLP, Consultant at Booz Allen Hamilton International (U.K.) Ltd., Chief Financial & Accounting Officer at Sio Gene Therapies, Inc. in 2015, Chief Financial Officer at Axovant Sciences, Inc. in 2015, and Senior Vice President & Member at Roivant Sciences, Inc. from 2014 to 2019.
Education includes undergraduate studies at Georgetown University, an MBA from Goizueta Business School-Emory, and graduate studies at Rollins School of Public Health.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
22/12/2025 49 514 ( 0,5 % ) 92 591 $ 31/05/2026

Postes actifs de Alan Roemer

SociétésPosteDébut
Directeur/Membre du Conseil -
Président 01/03/2020
Directeur/Membre du Conseil 01/06/2014

Anciens postes connus de Alan Roemer

SociétésPosteFin
IN8BIO, INC. Président 28/02/2026
Directeur/Membre du Conseil 01/11/2024
NEXIMMUNE, INC. Président 16/12/2019
Directeur/Membre du Conseil 01/02/2023
Corporate Officer/Principal 01/08/2019
Voir l'expérience en détail de Alan Roemer

Formation de Alan Roemer

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

53

Relations au 1er degré

21

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées21

Finance

Health Technology

Health Technology

Consumer Non-Durables

Health Technology

Commercial Services

Consumer Services

Finance

Commercial Services

Finance

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Sompharmaceuticals SA

  1. Bourse
  2. Insiders
  3. Alan Roemer
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇